Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic simvastatin + ezetimibe tablet versus Vytorin in healthy adults
TCTR20230620003Phase 1Completed
- Sponsor
- Duopharma Biotech
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of simvastatin and ezetimibe in hypercholesterolemia (2 arms), sponsored by Duopharma Biotech. Primary endpoint: Pharmacokinetic bioequivalence endpoints at 72.00 hours. Started Apr 2021; status: completed.
02
Drugs
simvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20230620003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230620003.